Download full-text PDF

Source
http://dx.doi.org/10.1227/ons.0000000000000225DOI Listing

Publication Analysis

Top Keywords

commentary central
4
central nervous
4
nervous system
4
system vasculitis
4
vasculitis post-covid-19
4
post-covid-19 infection
4
infection challenge
4
challenge histopathological
4
histopathological confirmation
4
commentary
1

Similar Publications

Letter to the article by Sasaki et al.

J Anesth

January 2025

Department of Obstetrics, School of Medicine, Chengdu Women and Children's Central Hospital, University of Electronic Science and Technology, Chengdu, Sichuan, China.

View Article and Find Full Text PDF

Interaction between bacterial adhesins leads to coaggregation by the oral bacteria and .

mBio

January 2025

Antimicrobial Resistance, Omics and Microbiota Group, Centre for Systems Health and Integrated Metabolic Research, Department of Biosciences, Nottingham Trent University, Nottingham, United Kingdom.

is an unusual diderm firmicute that plays a central role in the formation of dental biofilm formation through coaggregation with many other oral bacteria. However, the molecular interactions leading to oral biofilm formation are largely unknown. In a recent study (L.

View Article and Find Full Text PDF

Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel.

Neurol Ther

January 2025

Department of Psychiatry, Faculty of Medicine, Mental Health Unit, Virgen del Rocio University Hospital, Translational Psychiatry Group, IBiS-CSIC, CIBERSAM, University of Seville, Seville, Spain.

Introduction: For patients with psychosis, early, intensive therapeutic intervention is thought to improve long-term outcomes. Furthermore, patients with a first-episode psychosis (FEP) who experience a good early response to antipsychotic medication show a clinical and functional benefit over the longer term if they continue low-dose antipsychotic treatment. Lurasidone is an atypical antipsychotic agent which is approved in Europe for the treatment of schizophrenia in adults and adolescents (13-17 years).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!